Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 1, 2007, Pages

  De Preter, Vicky ^a   Vanhoutte, Tom ^b   Huys, Geert ^b   Swings, Jean ^b,c   De Vuyst, Luc ^d   Rutgeerts, Paul ^a   Verbeke, Kristin ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Ammonia; Bifidobacteria; Biomarker; P cresol

Indexed keywords

FRUCTOSE; INULIN; NITROGEN; OLIGOFRUCTOSE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIFIDOBACTERIUM BIFIDUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; LACTOBACILLUS CASEI; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS;

ADULT; BIFIDOBACTERIUM; COLON; CROSS-OVER STUDIES; FEMALE; FREEZE DRYING; GASTROINTESTINAL TRANSIT; HUMANS; INULIN; LACTOBACILLUS CASEI; MALE; NITROGEN; OLIGOSACCHARIDES; POLYETHYLENE GLYCOLS; PROBIOTICS; PROTEINS; REFERENCE VALUES;

EID: 33846156865     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00052.2006     Document Type: Article

References (40)

1. Andersson H, Asp NG, Bruce A, Roos S, Wadström T, Wold AE. Health effects of probiotics and prebiotics. A literature review on human studies. Scand J Nutr 45: 58-75, 2001.
2. Bammens B, Verbeke K, Vanrentherghem Y, Evenepoel P. Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int 64: 2196-2203, 2003.
3. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69: 1081-1087, 2006.
4. Birkett A, Muir J, Phillips J, Jones G, O'Dea K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr 63: 766-772, 1996.
5. Boure T, Vanholder R. Biochemical and clinical evidence for uremic toxicity. Artif Organs 28: 248-253, 2004.
6. Buddington RK, Williams CH, Chen SC, Witherly SA. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63: 709 -716, 1996.
7. Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B. PASSCLAIM-gut health and immunity. Eur J Nutr 43: 118-173, 2004.
8. 4]-tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. Br J Nutr 92: 439-446, 2004.
9. De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther 23: 963-974, 2006.
10. Fuller R. Probiotics in human medicine. Gut 32: 439-442, 1991.
11. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54: 242-249, 2005.
12. 15N]ureide as a tool to study colonic nitrogen metabolism. Am J Physiol Gastrointest Liver Physiol 288: G994-G999, 2005.
13. Goossens D, Jonkers D, Russel M, Stobberingh E, Van den Bogaard A, Stockbrügger R. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 18: 495-505, 2003.
14. Gosh S, van Heel D, Playford RJ. Probiotics in inflammatory bowel disease: is it all gut flora modulation. Gut 53: 620-622, 2004.
15. Guarner F. The intestinal flora in inflammatory bowel disease: normal or abnormal. Curr Opin Gastroenterol 21: 414-418, 2005.
16. Hofmann E. Ueber den Abbau von glucoseureid durch Bakterien. Biochem Z 243: 416-422, 1931.
17. Jenkins DJA, Kendall CWC, Vuksan V. Inulin, oligofructose and intestinal function. J Nutr 129: 1431S-1433S, 1999.
18. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352: 1187-1189, 1998.
19. Kleessen B, Hartmann L, Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr 89: 597-606, 2003.
20. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53: 1610-1616, 2004.
21. Marteau P, Lepage P, Mangin I, Suau A, Dore J, Pochart P, Seksik P. Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 20: 18-23, 2004.
22. Matsuki T, Wantanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in the human feces. Appl Environ Microbiol 68: 5445-5451, 2002.
23. 13C-enriched substrate synthesis by isotope ratio mass spectrometry. Rapid Commun Mass Spectrom 15: 1279-1282, 2001.
24. Muir JG, Walker KZ, Kaimakamis MA, Cameron MA, Govers MJAP, Lu ZX, Young GP, O'Dea K. Modulation of fecal markers relevant to colon cancer risk: a high-starch Chinese diet did not generate expected beneficial changes relative to a Western-type diet. Am J Clin Nutr 68: 372-379, 1998.
25. Pitcher DG, Saunders NA, Owen RJ. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 8: 151-156, 1989.
26. Roberfroid MB, Bornet F, Bouley C, Cummings JH. Colonic microflora: nutrition and health. Nutr Rev 53: 127-130, 1995.
27. Roberfroid MB. Concepts in functional foods: the case of inulin and oligofructose. J Nutr 129: 1398S-1401S,1999.
28. Roberfroid MB. Introducing inulin-type fructans. Br J Nutr 93: S13-S25, 2005.
29. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130: 396S-402S, 2000.
30. Rook G, Brunet LR. Microbes, immunoregulation and the gut. Gut 54: 317-320, 2005.
31. Salminen S, Ouwehand AC, Isolauri E. Clinical applications of probiotic bacteria. Int Dairy J 8: 563-572, 1998.
32. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I. Functional food science and gastrointestinal physiology and function. Br J Nutr 80: S147-S171, 1998.
33. Scheppach W, Luehrs H, Menzel T. Beneficial effects of low-digestible carbohydrate consumption. Br J Nutr 85: S23-S30, 2001.
34. Schoorl MN. Les ureides (carbamides) des sucres. Recl Trav Chim 22: 1, 1903.
35. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52: 237-242, 2003.
36. Shanahan F. Host-flora interactions in inflammatory bowel disease. Inflamm Bowel Dis 10: S16-S24, 2004.
37. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52: 899-907, 1998.
38. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol 13: 45-56, 1980.
39. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943, 2003.
40. Vanhoutte T, Huys G, De Brandt E, Swings J. Temporal stability analysis of the microbiota in human feces by denaturating gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48: 437-446, 2004.